ALLO
2.40 USD
+0.43%
Today
+0.43%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Allogene Therapeutics Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
Market Cap
663.08M
Avg Daily Volume
4.76M
52 Week High
2.95 USD
52 Week Low
0.86 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing technologies. The company is also developing cemacabtagene ansegedleucel (cema-cel), an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma (LBCL). In addition, it develops ALLO-316, an engineered allogeneic CAR T cell product candidate that targets CD70 to treat renal cell carcinoma (RCC); and ALLO-329, an engineered allogeneic CAR T cell product candidate that targets both CD19 and CD70 for the treatment of autoimmune diseases (AID), such as systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), and systemic sclerosis (SSc). The company was incorporated in 2017 and is headquartered in South San Francisco, California.
Top News
Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock
tradingview.com
2d ago
AmEagle
+1.26%
Allogene
+0.43%
Broadcom
+2.09%
BOAmerica
+0.54%
Allbirds
+0.93%
CSX.Corp
+1.50%
Precision.Bio
+4.74%
FirstHorizon
+1.38%
FNB_Corp
+3.59%
GitLab
-1.88%
RobinHood
+5.10%
IonQ.Inc
+4.59%
CarMax
+1.70%
EliLilly
+2.57%
MorganSt
+0.81%
NewmontM
+2.86%
NIKE
+0.63%
NatOilwell
-0.31%
NVIDIA
+1.88%
PDS.Biotech
+4.07%
PNCFin
+2.14%
Quantum.Computing
+2.26%
Rigetti.Computing
+2.49%
Revolution.Medicines
-0.86%
SnapInc
+0.00%
StoneCo
-1.25%
T1.Energy
+0.60%
Tempus.AI
+2.65%
UnionPacif
-0.02%
BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems
reuters.com
3d ago
AmEagle
+1.26%
Allogene
+0.43%
Broadcom
+2.09%
BOAmerica
+0.54%
Allbirds
+0.93%
CSX.Corp
+1.50%
Precision.Bio
+4.74%
FirstHorizon
+1.38%
FNB_Corp
+3.59%
GitLab
-1.88%
RobinHood
+5.10%
IonQ.Inc
+4.59%
CarMax
+1.70%
EliLilly
+2.57%
MorganSt
+0.81%
NewmontM
+2.86%
NIKE
+0.63%
NatOilwell
-0.31%
NVIDIA
+1.88%
PDS.Biotech
+4.07%
PNCFin
+2.14%
Quantum.Computing
+2.26%
Rigetti.Computing
+2.49%
Revolution.Medicines
-0.86%
SnapInc
+0.00%
StoneCo
-1.25%
T1.Energy
+0.60%
Tempus.AI
+2.65%
UnionPacif
-0.02%
BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financial, Papa John's
reuters.com
3d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
